Towards therapeutic stimulations of gd T cells

Published: June 8, 2009
Abstract Views: 156
PDF: 109
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Most vaccine strategies are designed to elicit adaptive immune responses to a variety of microbial or tumor-associated antigens. These immune responses are predominantly mediated by αβ T cells, B cells and antibodies. Nevertheless, approximately 1-5% of human peripheral blood lymphocytes possess the surface gd T-cell receptor, predominantly expressing the Vγ9Vδ2 variable segments.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Supporting Agencies

How to Cite

Malkovsky, M., Wallace, M., McNeel, D., Liu, G., Mejia, G., Kaikobad, M., Waterman, P., Samaniego, E., Bonneville, M., Fournie, J., Sicard, H., & Poccia, F. (2009). Towards therapeutic stimulations of gd T cells. Hematology Meeting Reports (formerly Haematologica Reports), 2(3). https://doi.org/10.4081/hmr.v2i3.367